Phase 1 Study of Cognitive Activation Behavioral Therapy for MCI: A Randomized Waitlist-Control and Delayed Active-Control Study
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Mild Cognitive Impairment
- Sponsor
- Rotman Research Institute at Baycrest
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Executive Function
- Last Updated
- 13 years ago
Overview
Brief Summary
Mild cognitive impairment (MCI) describes an initial phase of cognitive decline, usually among older adults, in which a person notices a decline in attention or memory, and performs worse than normal on cognitive tests of such. People with MCI are more likely to develop Alzheimer's disease or related dementia than others their same age, and so MCI is thought of as an early warning sign of progressive cognitive decline.
While some forms of MCI may be brought about by purely genetic causes, other cases may be due to a withdrawal of cognitive engagement with the world. In these cases, a rigorous program of cognitive training may be beneficial, halting or reversing symptom progression.
The current study will evaluate a multifaceted cognitive activation program on older adults with MCI. This group program is intensive, running for 10 weeks, 3 times per week, for a total of 100 hours of training. Training consists of meditation exercises for broad attention activation, Tai Chi exercises to integrate cognition with body awareness, and cognitive training through computerized attention, memory, and problem solving exercise.
Subjective impressions and objective measures of cognitive ability will be measured before and after the intervention. The investigators will also examine effects on mood and levels of daily function. Results will be compared to a waitlisted control group. The control group will subsequently be entered into a home-based version of the program for 10 weeks, with assessment before and after training, to look at the importance of the group meeting dynamic in promoting cognitive change.
Investigators
Norman Farb
Postdoctoral Fellow
Rotman Research Institute at Baycrest
Eligibility Criteria
Inclusion Criteria
- •Subjective complaint about decline in memory or attention
- •\> 1 deviation below age-norm performance on memory or attention tasks
- •Independence in daily living
- •English speaking
Exclusion Criteria
- •Neurological disorders (including aphasias) or reversible causes of dementia (e.g., hypothyroidism or B12 deficiency)
- •Montreal Cognitive Assessment (MOCA) score \< 24
- •Clinical mood disorder such as depression or anxiety
- •Other serious medical conditions that preclude participation in the program
Outcomes
Primary Outcomes
Executive Function
Time Frame: Before and After Intervention
Tests of inhibition, task switching, and problem solving.
Attention / Working Memory
Time Frame: Before and after intervention
Working memory measures such as digit span, selection of targets among distractors, etc.
Processing Speed
Time Frame: Before and After Intervention
Processing speed on computerized cognitive task.
Memory
Time Frame: Before and After Intervention
Tests of immediate recall and delayed recall, recognition, and familiarity.
Secondary Outcomes
- Daily Function(Before and after intervention)
- Mood and Well-being(Before and after intervention)